DJSP is a chart trying to find a bottom. The doji yesterday is a basic reversal pattern. The DJSP video chart is more than a “chart to watch.” It is a basic lesson in combining 15 minute charts with daily … Continue reading →

New York & Company, Inc. announced that the company’s expected loss for the second quarter of fiscal 2010 would be higher than was predicted at the previous guidance update given in May 2010. New York & Company, Inc. said that … Continue reading →

Oxford Industries, Inc. reported net income of $12.5 million, or $0.76 per diluted share, in the first fiscal quarter ending 5/1/2010. The company earned net income of $6.6 million, or $0.42 per diluted share, in the same quarter of 2009. … Continue reading →

It is often easy to run away from an investment when a particular segment is facing uncertain times. It is, however, just as easy to run toward that sector when others are fleeing if a longer time horizon is involved. … Continue reading →

RedChip Visibility, a division of RedChip Companies, Inc., yesterday announced its initiation of coverage on NetSol Technologies Inc., a developer and implementer of global business services and enterprise application solutions. Bill Matson, CFA, RedChip Research Analyst, stated, “NetSol’s global footprint, … Continue reading →

Kansas City Life Insurance Company announced that after a review of the financial strength of the company, A.M. Best has affirmed the financial strength and issuer credit ratings of Kansas City Life Insurance Company as an “A.” The ratings affirmation … Continue reading →

Yesterday, representatives from Immunovaccine Inc. announced that the company has signed a collaborative research agreement with Vaxil BioTherapeutics. The research agreement aims to explore the efficacy of Vaxil’s cancer antigens in its Immunovaccine’s DepoVax™ vaccine enhancement platform. Headquartered in Israel, … Continue reading →

Pizza Inn, Inc. recently announced a development agreement with one of its existing licensees to open an additional 44 Pizza Inn locations in Saudi Arabia over the next 5 years. The company said that this would bring its locations in … Continue reading →

Talecris Biotherapeutics is a US-based biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology, hemostasis and critical care. The company announced today … Continue reading →

ZymoGenetics Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human diseases such as hepatitis C, metastatic melanoma, psoriasis, diabetes, atopic dermatitis and more. The company has secured collaboration agreements with … Continue reading →